tertiary oncology centremyelomabrexucabtagene autoleucelbrexi-celtisagenlecleucelaxicabtagene ciloleuceltisa-celaxi-celchemo refractory aggressive B-cell lymphomas
…V2Vt in patients receiving autologous CAR T-cell therapies at a tertiary oncology centre, and to compare differences across available products.Material …